|
|
|
|
|
|
| Special Feature |
 |
|
Pharm Exec’s Brand of the Year 2016 |
Pharm Exec’s 10th annual Brand of the Year is Bristol-Myers Squibb's Opdivo, which has raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers—melanoma, lung, and renal
/Read more/ |
|
|
|
| Industry update |
//Envigo (Huntingdon, UK) announced that it has appointed Patricia Henahan as Chief Financial Officer.//Celyad (Mont-Saint-Guibert, Belgium) announced the appointment of Dr. David Gilham as Vice-President of Research & Development, effective September 1, 2016.//Dr. Richard Butt was named Chief Executive Officer of Apollo Therapeutics.
//Eyevensys (Paris, France) appointed Dr. Patricia Zilliox to its Board of Directors.//Univac (Brussels, Belgium) announced the appointments of Stefano Malvolti, MSc, MPH to the position of Chief Executive Officer and Tyler Martin, M.D., as Independent Director and Chairman of its Board of Directors.// |
|
|
| |
|
|
